Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 396)
Posted On: 01/15/2021 12:28:56 PM
Post# of 154185
Avatar
Posted By: ClosetInvestor
Re: CDiddy #72858
“Back to my thought. The endpoints in M2M were more complex and thus required more analysis.”

Were the M2M endpoints more complex? They don’t appear to be.

The primary endpoint was a change in total symptom score at 14 days. That’s simple addition and subtraction of the scores provided by the clinical sites.

The top listed secondary endpoint was time to clinical resolution at day 14. That’s more simply to calculate then the primary endpoint.

NEWS2 at day 3, 7, and 14 was the next secondary endpoint listed on clinicaltrials.gov. That could take more time to calculate as NEWS2 includes 7 parameters.

The other secondary endpoints were fairly straight forward, such as mortality, incidence of hospitalization, duration of hospital stay, incidence of oxygen use and duration of oxygen use.













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site